| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/20/2008 | US7374932 Human kinases and polynucleotides encoding the same, and uses thereof |
| 05/20/2008 | US7374931 Vaccine against staphylococcus intoxication |
| 05/20/2008 | US7374930 GLP-1 gene delivery for the treatment of type 2 diabetes |
| 05/20/2008 | US7374925 Penicillium funiculosum mutant strain |
| 05/20/2008 | US7374923 cleaves the insulin-like growth factor binding proteins 3 and 5; screening for a therapeutic agent for type II diabetes, particularly for alleviating insulin resistance |
| 05/20/2008 | US7374922 Starch debranching enzymes |
| 05/20/2008 | US7374921 Cellulase tolerant to surfactants |
| 05/20/2008 | US7374920 geranylgeranyl diphosphate to levopimaradiene; for cloning and characterization of a Ginkgo biloba sequence for biosynthesis of ginkgolides; Saccharomyces cerevisiae or Escherichia coli, comprising levopimaradiene synthase for metabolically engineered in vivo biosynthesis of a diterpene and ginkolide |
| 05/20/2008 | US7374918 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders |
| 05/20/2008 | US7374917 Enzymatic polypeptide comprising aldo-keto reductases activity for use in conversion of glucose to vitamin C; bioreactors |
| 05/20/2008 | US7374913 Method for synthesizing polynucleotides |
| 05/20/2008 | US7374912 Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/20/2008 | US7374911 Cytokine polypeptide for use in diagnosis, prevention and treatment of immunological and/or inflammatory disorders |
| 05/20/2008 | US7374910 agonist; a memory function improving agent, appetite regulator; an uterine, renal, testis, spleen, heart, prostatic or skeletal muscle function improving agent; antiobesity agent, antiabetic |
| 05/20/2008 | US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector |
| 05/20/2008 | US7374899 Sucrose-6-phosphate phosphatase as target for herbicides |
| 05/20/2008 | US7374896 GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity |
| 05/20/2008 | US7374895 Guanosine triphosphate (GTP) binding protein-coupled receptor proteins that bind histamine and are expressed in the brain |
| 05/20/2008 | US7374894 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 05/20/2008 | US7374892 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/20/2008 | US7374889 Human sphingosine-1-phosphate phosphatase and inhibition methods |
| 05/20/2008 | US7374882 Method for base sequencing and biologically active nucleic acids |
| 05/20/2008 | US7374881 Detecting gene expression in cells, comprising trapping cell on filter or membrane, contacting cell with membrane permeation solution, dissolving membrane, recovering and analyzing messenger RNA using oligonuclelotide column |
| 05/20/2008 | US7374877 Amplification of HIV-1 gag sequences for detection of sequences associated with drug-resistance mutations |
| 05/20/2008 | US7374872 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 05/20/2008 | US7374767 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN |
| 05/20/2008 | US7374758 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders |
| 05/20/2008 | US7374757 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF) to patient in need thereof, wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and a multimerizing component; eye disorders |
| 05/20/2008 | US7374752 Reovirus for the treatment of cellular proliferative disorders |
| 05/20/2008 | CA2469833C Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 05/20/2008 | CA2456070C Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity |
| 05/20/2008 | CA2331333C Antisense oligonucleotide constructs based on .beta.-arabinofuranose and its analogues |
| 05/20/2008 | CA2303414C Non-competitive co-amplification methods |
| 05/20/2008 | CA2283231C Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/20/2008 | CA2128862C Homogenotization of gene-targeting events |
| 05/15/2008 | WO2008058204A1 Dna purification in a multi-stage, multi-phase microchip |
| 05/15/2008 | WO2008058035A1 Alphavirus and alphavirus replicon particle formulations and methods |
| 05/15/2008 | WO2008057642A1 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions |
| 05/15/2008 | WO2008057234A2 Modulation of t cell signaling threshold and t cell sensitivity to antigens |
| 05/15/2008 | WO2008056994A1 Method of identifying individuals at risk of thiopurine drug resistance and intolerance |
| 05/15/2008 | WO2008056937A1 Method and kit for determining chimerism after stem cell transplantation using mitochondrial dna microsatellites as markers |
| 05/15/2008 | WO2008056833A1 ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO |
| 05/15/2008 | WO2008056816A1 Suspension support for linear nucleic acid molecule, method of extending linear nucleic acid molecule and linear nucleic acid molecule specimen |
| 05/15/2008 | WO2008056759A1 Method for production of dipeptide |
| 05/15/2008 | WO2008056734A1 Method for producing dendritic cells from human embryonic stem cells |
| 05/15/2008 | WO2008056705A1 M cell-specific antibody |
| 05/15/2008 | WO2008056653A1 Microorganism capable of controlling plant diseases and plant disease-controlling agent using the microorganism |
| 05/15/2008 | WO2008056623A1 Composition for introduction of nucleic acid |
| 05/15/2008 | WO2008056265A2 A set of sequences for targeting expression and control of the post-translationnal modifications of a recombinant polypeptide |
| 05/15/2008 | WO2008056106A1 Transgenic non-human animal |
| 05/15/2008 | WO2008055924A1 Diagnosis and treatment of t-cell acute lymphoblastic leukemia |
| 05/15/2008 | WO2008055795A1 Selection of human monoclonal antibodies by mammalian cell display |
| 05/15/2008 | WO2008055530A1 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases |
| 05/15/2008 | WO2008055361A1 E3 UBIQUITM LIGASE MKRNL AS A MARKER FOR MAMMALIAN STEM CELL PLUπPOTENCY AND METHODS AND USES THEREOF |
| 05/15/2008 | WO2008055354A1 Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods |
| 05/15/2008 | WO2008055347A1 Prediction of potential drug-drug interactions using gene expression profiling of drug transporters, cytochrome p450s and nuclear x receptors |
| 05/15/2008 | WO2008055316A1 Methods and devices for the delivery of peptides into the gastric mucosa |
| 05/15/2008 | WO2008037490A3 Galactosyltransferase |
| 05/15/2008 | WO2008034866A3 Dbait and uses thereof |
| 05/15/2008 | WO2008015263A3 Plants having improved characteristics and a method for making the same |
| 05/15/2008 | WO2008014603A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/15/2008 | WO2007148079A3 A molecular tool to enhance salt tolerance in an organism |
| 05/15/2008 | WO2007147064A3 Modified soy proteins and methods of use |
| 05/15/2008 | WO2007146106A3 Procurement, isolation and cryopreservation of maternal placental cells |
| 05/15/2008 | WO2007136893A3 Anti-fgf19 antibodies and methods using same |
| 05/15/2008 | WO2007133425A3 Fungal delta12 desaturase and delta15 desaturase motifs |
| 05/15/2008 | WO2007103767A3 Role of microrna in plant salt tolerance |
| 05/15/2008 | WO2007089038A8 Novel phospholipase d |
| 05/15/2008 | WO2007086935A8 Methods of amplifying and sequencing nucleic acids |
| 05/15/2008 | WO2007084630A3 Mutant jak3 kinase in human leukemia |
| 05/15/2008 | WO2007076351A3 Rnai-mediated inhibition of hif1a for treatment of ocular angiogenesis |
| 05/15/2008 | WO2007050866A8 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof |
| 05/15/2008 | WO2007038130A8 Improved strains for the production of organic acids |
| 05/15/2008 | WO2007031727A3 System for delivering neuronal calcium sensor - 1 (ncs - 1) |
| 05/15/2008 | US20080115244 Therapeutic antibodies comprising protective proteins for use in treatment and prevention of dental caries and streptococal infection; dentristry |
| 05/15/2008 | US20080115243 Transgenic Plants Expressing Intein Modified Proteins and Associated Processes for Bio-Pharmaceutical Production |
| 05/15/2008 | US20080115241 Expression vector comprising nucleotide sequences coding latobacillus hydrolase for use in enhancing digestibility of animal feeds |
| 05/15/2008 | US20080115240 Rna sequences for use targeted gene expression in plants; propagating disease and drought resistant plants |
| 05/15/2008 | US20080115239 Plants Having Increased Yield And Method For Making The Same |
| 05/15/2008 | US20080115237 Novel ecdysone receptor-based inducible gene expression system |
| 05/15/2008 | US20080115236 Using allelic mutation in corticosteroid-binding globulin gene (CBG) as diagnostic indicator of cushing's, eating, inflammatory and glandular disorders |
| 05/15/2008 | US20080115233 Conditional lethal animal systems for use in single sex biological control |
| 05/15/2008 | US20080115232 Amphidiploid Aquatic Animal and Method of Breeding the Same |
| 05/15/2008 | US20080114162 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113931 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, substantially complementary to at least part of an mRNA transcript of an Aha gene; cancer or cystic fibrosis |
| 05/15/2008 | US20080113930 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, complementary to at least a part of the PCSK9 gene; antihyperlipemia agent |
| 05/15/2008 | US20080113928 Modified Cea/B7 Vector |
| 05/15/2008 | US20080113917 A fusion protein expressed in a protease resistant scaffold and protease inhibitor is selected from the group consisting of Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor; capable of modulating human hair growth |
| 05/15/2008 | US20080113906 Sushi Peptide Multimer |
| 05/15/2008 | US20080113449 G protein coupled receptor specific immunoglobulin for use in treatment and prevention of cell proliferative, cardiovascular and metabolic disorders |
| 05/15/2008 | US20080113437 In-vitro method for producing oocytes or eggs having targeted genomic modification |
| 05/15/2008 | US20080113436 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 05/15/2008 | US20080113435 Transforming bone marrow stromal cells with vector comprising notch receptor, exposing cells to jagged 1 protein, culture and recover myoblast |
| 05/15/2008 | US20080113430 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 05/15/2008 | US20080113429 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113417 Gene Sms 12 |